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Basal cell carcinoma (BCC) is the most common malig-
nant neoplasm of the skin, and accounts for 90–95%
of malignant eyelid tumors. However, occurrence of
BCC in the lacrimal caruncle is extremely rare. A search
of the literature found only seven illustrated reports
of primary caruncular BCCs [1–6]. Here, to the best of
our knowledge, we report the first case of primary
pigmented caruncular BCC in an Oriental patient and
review the previous seven cases.
CASE PRESENTATION
A 73-year-old Chinese man presented with an iso-
lated, multilobulated mass over the left caruncle, with-
out a connection to the surrounding periorbital and
eyelid skin (Figure 1). The lesion was brown–black,
with a telangiectatic, irregular surface (5 × 5 mm), and
the tumor had been growing painlessly without ulcer-
ation for 3 months. Other ophthalmic examination was
normal, except for bilateral cataract. The patient was
a mechanical designer, without excessive sun exposure
or a family history of malignancy. A review of his med-
ical history revealed that he had hypertension and
coronary artery disease but no other malignancy.
Under local anesthesia, the tumor, along with the
entire caruncle was excised using a “no touch” tech-
nique. The tumor did not invade deeply into the orbit
and extended only to the subcutaneous tissue.
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Although basal cell carcinoma (BCC) is the most common eyelid neoplasm, BCC that originates
from the lacrimal caruncle is extremely rare. To the best of our knowledge, only seven cases have
been reported and here we report the first documented primary caruncular BCC in an Oriental
patient. A 73-year-old Chinese man presented with a telangiectatic, multilobulated, pigmented
tumor that measured 5 × 5 mm, which had arisen from the lacrimal caruncle of the left eye 
3 months previously. The patient underwent tumor excision, and histopathological examination
revealed BCC. He received adjuvant chemotherapy with intra-arterial methotrexate (30 mg/m2).
A nodular pigmented BCC recurred in the bulbar conjunctiva close to the original tumor 3
months later, and he underwent a second excision. Bleomycin (8.5 mg/m2 monthly) was added
to the chemotherapy regimen, which was changed to fluorouracil (300 mg/m2 monthly) 2
months later. The tumor did not recur during follow-up of 22 months. Malignant tumors of the
caruncle are infrequent. BCC should be considered in the differential diagnosis of a pigmented
caruncular lesion.
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Histopathology showed infiltrative islands of basa-
loid cells, with characteristic retraction spaces between
tumor islands and surrounding stroma. Elongated
nuclei and scanty cytoplasm with peripheral nuclear
palisades were consistent with BCC (Figure 2A). Mel-
anin pigmentation was found in clumps (Figure 2B).
Owing to inadequate surgical margins in the patho-
logical report, the patient was referred to an oncologist
for adjuvant intra-arterial chemotherapy. After chemo-
therapy with methotrexate (30 mg/m2 monthly) for 
3 months, one small (2 × 1 mm) pigmented, nodular
conjunctival tumor was noted close to the resected
caruncle. A second tumor excision revealed recurrent
BCC. Another exploratory biopsy of pigmented lesions
in the bulbar conjunctiva did not show any malig-
nancy. Bleomycin (8.5 mg/m2 monthly) was added 
to the chemotherapy regimen, which was changed 
to fluorouracil (300 mg/m2 monthly) 2 months later.
Follow-up examination over an additional 22 months
showed no evidence of tumor recurrence.
DISCUSSION
The histogenesis of BCC is unclear. Either pluripoten-
tial germ cells in the deepest layer of the epidermis, or
basal cells of pilosebaceous structures have been pro-
posed to develop into carcinoma. The caruncle serves
a transition zone between the skin and conjunctiva. 
It has a non-keratinized epithelial lining similar to
the conjunctival epithelium, and harbors skin elements
such as hair follicles, sebaceous glands, accessory
lacrimal glands and sweat glands. Consequently, BCC
is likely to occur in the caruncle.
Of the eight primary caruncular BCCs reviewed in
the literature, including this present case and seven
previous cases, male cases (n = 6) were more common
than female cases (n = 2) (Table) [1–6]. Patient ages
ranged from 24 to 82 years, with five being older than
60 years. All the previous seven cases were from
North America or Europe. Our report is believed to
be the first case of an Oriental patient with caruncular
BCC. Of the seven previous cases, five of the tumors
were described as pale, vascularized and lobulated
Figure 2. (A) Basaloid tumor islands with peripheral nuclear palisade (arrow) and typical retraction spaces (asterisk) (hematoxylin
and eosin stain, 100×). (B) Pigment clumps between pleomorphic neoplastic cells. The diagnosis was a pigmented basal cell carcinoma
(hematoxylin and eosin stain, 200×).
A B
Figure 1. Darkly pigmented, multi-lobular, non-ulcerative
tumor on left caruncle, 5 × 5 mm. Adjacent eyelid skin was free of
tumor.
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nodules, whereas the other two were brown to black
and similar to our tumor with dark pigmentation. Two
patients had other skin cancers, including BCC and
squamous cell carcinoma at sites distant from the
eyelids. A majority of cases, in which eyelid BCC grows
into caruncle, are not included in this series of reviews.
Complete excision of BCC with a tumor-free surgi-
cal margin is the principal primary treatment; however,
radical excision with a wide margin in the caruncular
area is difficult. The prognosis is worse once the
tumor invades the orbit [4]. Ostergaard et al reported
a case of caruncular BCC that recurred and extended
into the orbit [4]. Rossman et al reported a tumor that
received adjuvant radiotherapy because of an uncer-
tain tumor-free margin after surgical resection [5]. The
patient in the present report received adjuvant intra-
arterial chemotherapy. Intra-arterial infusion of chemo-
therapeutic drugs provides selective and increased
perfusion of antineoplastic agents into the tumor, and
local control of BCC using such chemotherapy has been
reported [7]. Extensive BCCs on the wrist and thigh
have been reported to respond to a combination of sys-
temic and intra-arterial chemotherapy [6]. Large and
unresectable BCC in the head and neck region had an
83% response rate when treated with intra-arterial che-
motherapy using a combination of vincristine, bleo-
mycin, methotrexate, and cisplatin [7]. Nevertheless,
intra-arterial chemotherapy-induced stroke was a con-
cern in this patient as he had cardiovascular disorders.
Radiotherapy is another optional adjuvant treat-
ment of excised BCC in the medial canthal region,
with a response rate better than 90% [8–10]. Our
patient chose to receive intra-arterial chemotherapy
after consultations with the surgical oncologist and
therapeutic radiologist.
Various histopathological lesions have been re-
ported from caruncles. The most common lesions are
nevi and papillomas [11]. Other benign lesions include
pyogenic granuloma, chronic inflammatory lesion, epi-
dermoid cyst, dermoid cyst, epithelial inclusion cyst,
oncocytoma, and sebaceous gland hyperplasia. Pri-
mary malignant tumors that arise from caruncles are
unusual. BCC, Kaposi’s sarcoma, keratoacanthoma,
and sebaceous gland carcinoma have been reported
[11,12]. The majority of malignant caruncular BCCs
spread from the eyelid or medial canthus, but in our
case, this was unlikely. If there had been any lesion in
the adjacent skin, it would have grown to a remarkable
size during follow-up of 22 months. In the first impres-
sion, this well-defined, darkly pigmented, caruncular
nodule would have been considered to be a nevus.
Nevertheless, its rapid growth suggested malignancy,
and therefore, histopathological diagnosis was essential.
In conclusion, primary lacrimal caruncular BCC 
is rarely encountered. It has various presentations
including pale, pink to darkly pigmented, cystic to
lobulated, or nodular. Accurate diagnosis relies on
photographically documented follow-up and timely
Table. Reported cases of primary caruncular basal cell carcinoma
Publication, year
Age 
Clinical appearance Treatment
Recurrence Associated 
Reference
(yr)/Sex (follow-up) neoplasm
Poon et al, 1997 74/M Multilobulated nodule, Excision – SCC, BCC 1
vascularized, pink
Meier et al, 1998 24/M Nodule, vascularized, Excision No (14 mo) No 2
white, red center
Mencia-Gutierrez 80/M Irregular, brown–black, Excision No (7 yr) No 3
et al, 2005 vascularized
Ostergaard et al, 60/F Lobulated, cystic Excision Yes (5.5 yr) No 4
2005 nodule, vascularized, 
pale, 3 × 4 mm
Rossman et al, 82/M Nodule, pale Excision, adjuvant No (6 mo) Periauricular 5
2006 radiotherapy skin cancer
Kaeser et al, 2006 72/F Cyst Excision No (–) – 6
Kaeser et al, 2006 52/M Nodule, black Excision No (–) – 6
Present case 73/M Lobulated, Excision, IA Yes (22 mo) No
brown–black chemotherapy
SCC = Squamous cell carcinoma; BCC = basal cell carcinoma; IA = intra-arterial; – Not stated.
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histopathological examination of suspicious lesions.
The treatment of choice is complete excision with
tumor-free surgical margins. If complete tumor resec-
tion is not achieved, adjuvant radiotherapy or chemo-
therapy should be considered.
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發生於中國病人之
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基底細胞癌（BCC）是眼瞼最常見的惡性腫瘤，但原發於淚阜（lacrimal caruncle）的
BCC則極為罕見，至今僅有七例案例報告。本文為第一例東方人之原發性淚阜 BCC
病例報告。一位 73 歲台灣男性於左眼淚阜處發現一深色多葉狀腫塊，表面呈毛細血
管擴張，於 3 個月內增長至 5 × 5 mm大。該病患接受腫瘤切除之病理診斷為 BCC，
術後並接受 methotrexat （30mg/m
2
 monthly）之輔助動脈內化療。三個月後於近原病
灶之結膜處發生復發性 BCC。手術切除後加入 bleomycin（8.5mg/m
2
 monthly）及
fluouracil（300mg/m
2
 monthly）動脈內化療。追蹤至今共 22 個月，未有再次復發。
原發自淚阜的惡性腫瘤相當罕見，對於淚阜處的深色病灶，BCC須列入鑑別診斷之
列。
關鍵詞：基底細胞癌，淚阜，眼腫瘤
（高雄醫誌 2010;26:562–6）
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